CACNA1S
CACNA1S (calcium voltage-gated channel subunit alpha1 S, also known as Cav1.1) is the pore-forming alpha-1S subunit of the L-type voltage-gated calcium channel in skeletal muscle. It underpins excitation-contraction coupling and is linked to several inherited muscle disorders. Browse Assay Genie's current range of CACNA1S research reagents below, or read on for the biology behind the target.
CACNA1S encodes the pore-forming alpha-1S subunit of the voltage-gated calcium channel that gives rise to L-type calcium currents in skeletal muscle. Long-lasting (L-type) channels belong to the high-voltage activated (HVA) group. Channels containing the alpha-1S subunit play an important role in excitation-contraction coupling: through their interaction with RYR1, they trigger Ca(2+) release from the sarcoplasmic reticulum, which ultimately results in muscle contraction.
The CACNA1S gene encodes one of the five subunits of the slowly inactivating L-type voltage-dependent calcium channel in skeletal muscle cells. The protein is localised to the cell membrane, specifically the sarcolemma and the T-tubule. It belongs to the calcium channel alpha-1 subunit family (TC 1.A.1.11) and the CACNA1S subfamily, and sits in the HGNC gene group of calcium voltage-gated channel alpha1 subunits. Mouse and rat both carry a Cacna1s ortholog, which allows the channel to be studied in rodent models.
Mutations in the CACNA1S gene have been associated with hypokalemic periodic paralysis, thyrotoxic periodic paralysis and malignant hyperthermia susceptibility. Symbols and names you may meet in the literature include Cav1.1, hypoPP, HOKPP, MHS5 and CACNL1A3, and the earlier gene name was calcium channel, voltage-dependent, L type, alpha 1S subunit. Researchers studying the CACNA1S protein often work on muscle physiology, channelopathies and calcium handling.
The alpha-1S subunit interacts with RYR1 to trigger Ca(2+) release from the sarcoplasmic reticulum, making it central to skeletal muscle contraction.
Mutations in CACNA1S are associated with hypokalemic periodic paralysis and thyrotoxic periodic paralysis.
CACNA1S variants are associated with malignant hyperthermia susceptibility, a disorder of skeletal muscle calcium regulation.
As an HVA, slowly inactivating L-type channel subunit, CACNA1S is a reference point for comparing calcium channel alpha-1 subunits.
CACNA1S encodes the pore-forming alpha-1S subunit of the L-type voltage-gated calcium channel in skeletal muscle. Through its interaction with RYR1, it triggers Ca(2+) release from the sarcoplasmic reticulum, which ultimately results in muscle contraction. This is the basis of excitation-contraction coupling.
CACNA1S is also called Cav1.1, hypoPP, HOKPP, MHS5 and CACNL1A3. The previous gene name was calcium channel, voltage-dependent, L type, alpha 1S subunit. UniProt lists the protein as voltage-dependent L-type calcium channel subunit alpha-1S.
Mutations in CACNA1S are associated with hypokalemic periodic paralysis, thyrotoxic periodic paralysis and malignant hyperthermia susceptibility. Orthologs named Cacna1s exist in mouse and rat. Check the datasheet of any product for its validated reactivity.
Other calcium voltage-gated channel alpha1 subunits that sit alongside CACNA1S in the same gene group.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q13698; product specifications from Assay Genie datasheets.